Trends in multimodality cardiac imaging utilization for Takotsubo syndrome hospital admissions in the United States (2017-2023) [0.03%]
美国 takotsubo 综合征住院患者多模态心脏影像应用趋势（2017-2023）
Taha Ahmed,Gabriel Najarro,Jingwen Huang et al.
Taha Ahmed et al.
Radionuclide imaging techniques for assessing myocardial viability: Clinical applications, evidence, and future directions [0.03%]
核素显像评估心肌存活的临床应用、证据及未来发展方向
Jonathan D Knott,Ellen Kronzer,Nandan Anavekar et al.
Jonathan D Knott et al.
Ischemic cardiomyopathy (ICM) is a leading cause of heart failure globally. Myocardial viability testing aims to identify dysfunctional but potentially reversible myocardium in patients with ICM. This review examines the clinical applicatio...
Updates in fluorodeoxyglucose positron emission tomography (18FDG-PET) in the diagnosis and management of cardiac sarcoidosis [0.03%]
心肌淋巴细胞性心肌炎18F-脱氧葡萄糖正电子发射断层扫描(18FDG-PET)诊断和治疗的最新进展
Ellen Kronzer,Grace Hagan,Caroline Ledet et al.
Ellen Kronzer et al.
Cardiac sarcoidosis (CS) is an infiltrative cardiomyopathy characterized by non-caseating granulomatous inflammation that results in significant morbidity and mortality. It has become increasingly recognized over the past several decades; h...
Left atrial remodeling trajectories in hypertrophic cardiomyopathy: Reframing prognostic assessment through a dynamic lens [0.03%]
肥厚性心肌病左心房重塑轨迹：通过动态视角重新评估预后
Luigi Badano,Valeria Rella,Lia Crotti et al.
Luigi Badano et al.
Hypertrophic cardiomyopathy (HCM) is increasingly recognized as a condition involving not only the left ventricle but also the left atrium (LA). In this issue of Progress in Cardiovascular Diseases, Di Napoli et al. provide compelling evide...
Recent and ongoing developments in electrophysiology science and treatment [0.03%]
电生理学的近期和当前发展及治疗手段
Daniel P Morin,Mina K Chung
Daniel P Morin
Somayeh Makvandi,Leila Karimi,Mona Larki et al.
Somayeh Makvandi et al.
Introduction: Pregnancy induces significant metabolic changes, including altered lipid profiles, yet the role of lipoprotein(a) [Lp(a)] remains unclear. While Lp(a) levels rise during pregnancy and may be linked to compli...
Advancing familial hypercholesterolaemia management: real-world evidence for inclisiran's impact on LDL-C and arterial stiffness [0.03%]
载脂蛋白遗传性高胆固醇血症的管理：Inclisiran对LDL-C和动脉僵硬度影响的真实世界证据
Amany Elshorbagy,Kausik K Ray
Amany Elshorbagy
Transthyretin amyloid cardiomyopathy: Evolving therapies, expanding hope [0.03%]
transthyretin淀粉样变性心肌病：不断发展的疗法和充满希望的前景
Juan Pablo Costabel,Leonardo Lucas Suarez,Yogita Rochlani et al.
Juan Pablo Costabel et al.
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive and life-threatening condition characterized by the deposition of misfolded transthyretin (TTR) protein in the myocardium, leading to restrictive cardiomyopathy and heart failu...
Atherogenic dyslipidemia: A marker of cardiovascular risk in treated hypertension [0.03%]
治疗高血压患者的致动脉粥样硬化性脂质异常作为心血管风险的标志
Waqas A Malick,Omar Al Dhaybi,Deepak L Bhatt
Waqas A Malick
Maham F Karatela,Hugh Calkins
Maham F Karatela
The treatment for atrial fibrillation has evolved significantly over time. Previously, medication management was the mainstay of treatment. As we have developed more robust technologies and modalities for catheter ablation, these treatment ...